ASA is considered as non-steroidal anti-inflammatory drugs (NSAIDs), which is able to ease the inflammation, the primary pathogenic insult of diabetes progress, by inhibiting the prostaglandins synthesis and cyclooxygenase-2 (COX2) [22]. This evidence concerns the gene PTGS2 and diabetes mellitus.